BTIG Research raises its price target on BrightSpring Health Services (NASDAQ:BTSG) to $20.00

VaselineOctober 3, 2024

0 2 minutes read

BrightSpring Health Services (NASDAQ:BTSG – Get a Free Report) had its price objective raised by stock analysts at BTIG Research from $15.00 to $20.00 in a research report issued to clients and investors on Thursday, Benzinga reports. The brokerage currently has a “buy” rating on the stock. BTIG Research’s price objective would indicate a potential upside of 35.04% from the company’s current price.

BTSG has been the subject of several other research reports. Guggenheim lifted their price objective on BrightSpring Health Services from $15.00 to $18.00 and gave the company a “buy” rating in a research note on Tuesday. Goldman Sachs Group dropped their price objective on shares of BrightSpring Health Services from $21.00 to $18.00 and set a “buy” rating on the stock in a research report on Friday, August 9th. Twelve analysts have rated the stock with a buy rating. The company has a consensus rating of “Buy” and an average target price of $16.05, according to MarketBeat.

Read the latest stock report on BTSG

BrightSpring Healthcare trading rose 0.2%

Want more great investment ideas?

NASDAQ BTSG opened at $14.81 on Thursday. The company has a debt-to-equity ratio of 1.62, a quick ratio of 1.00, and a current ratio of 1.33. The stock’s 50-day simple moving average is $12.94 and its 200-day simple moving average is $11.60. BrightSpring Health Services has a 1 year low of $7.85 and a 1 year high of $15.47.

BrightSpring Health Services (NASDAQ:BTSG – Get Your Free Report ) last posted its quarterly earnings results on Friday, August 2nd. The company reported $0.10 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.18 by ($0.08). The firm had revenue of $2.73 billion during the quarter, compared to analyst estimates of $2.61 billion. The company’s revenue for the quarter was up 26.0% compared to the same quarter last year. research analysts anticipate that BrightSpring Health Services will post 0.57 earnings per share for the current year.

Insider buying and selling

In other news, major shareholder Kkr Group Partnership LP purchased 11,619,998 shares of the company’s stock in a transaction that occurred on Wednesday, September 11th. The shares were purchased at an average price of $11.13 per share, with a total value of $129,330,577.74. Following the purchase, the insider now owns 92,959,984 shares of the company’s stock, valued at approximately $1,034,644,621.92. The acquisition was disclosed in a legal filing with the SEC, which is accessible via this hyperlink.

Institutional investors are investing in BrightSpring Health Services

Large investors have recently made changes to their positions in the company. nVerses Capital LLC acquired a new stake in BrightSpring Health Services in the second quarter valued at about $55,000. Ameritas Investment Partners Inc. bought a new position in BrightSpring Health Services in the first quarter worth $58,000. California State Teachers Retirement System bought a new position in BrightSpring Health Services in the first quarter worth $59,000. Zurcher Kantonalbank Zurich Cantonalbank acquired a new position in BrightSpring Health Services during the 2nd quarter valued at $126,000. Finally, Arizona State Retirement System purchased a new stake in BrightSpring Health Services in the second quarter valued at $163,000.

About BrightSpring Health Services

(Get a free report)

BrightSpring Health Services, Inc operates a home and community healthcare platform in the United States. The company’s platform focuses on providing pharmacy and provider services, including clinical and supportive care in home and community settings for Medicare, Medicaid and insured populations.